Difference between revisions of "Template:Lymphoid and complement immunodeficiency"
Jump to navigation
Jump to search
imported>Tom (LT) m (per Template_talk:Medicine_navs#Background_colours, remove unnecessary and confusing background colours using AWB) |
imported>Frozenimpact |
||
| (8 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = Lymphoid and complement immunodeficiency |
| − | | title = | + | | title = [[Lymphatic system|Lymphoid]] and [[Complement system|complement]] disorders causing [[immunodeficiency]] |
| − | |listclass = hlist | + | | state = {{{state|}}} |
| + | | listclass = hlist | ||
| + | | group1 = [[Primary immunodeficiency|Primary]] | ||
| + | | list1 = {{Navbox|child | ||
| + | | group1 = [[Antibody]]/[[Humoral immune deficiency|humoral]]<br/>([[B cell|B]]) | ||
| + | | list1 = {{Navbox|child | ||
| − | + | | group1 = [[Hypogammaglobulinemia]] | |
| − | + | | list1 = | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | | group1 = [[Hypogammaglobulinemia]] | ||
| − | | list1 | ||
* [[X-linked agammaglobulinemia]] | * [[X-linked agammaglobulinemia]] | ||
* [[Transient hypogammaglobulinemia of infancy]] | * [[Transient hypogammaglobulinemia of infancy]] | ||
| − | | group2 = [[Dysgammaglobulinemia]] | + | | group2 = [[Dysgammaglobulinemia]] |
| − | | list2 | + | | list2 = |
* [[Selective immunoglobulin A deficiency|IgA deficiency]] | * [[Selective immunoglobulin A deficiency|IgA deficiency]] | ||
| − | * [[ | + | * [[IgG deficiency]] |
* [[Immunoglobulin M deficiency|IgM deficiency]] | * [[Immunoglobulin M deficiency|IgM deficiency]] | ||
| − | * [[Hyper IgM syndrome]] ([[Hyper-IgM syndrome type 2|2]] | + | * [[Hyper IgM syndrome]] ([[Hyper-IgM syndrome type 1|1]] |
| + | * [[Hyper-IgM syndrome type 2|2]] | ||
* [[Hyper-IgM syndrome type 3|3]] | * [[Hyper-IgM syndrome type 3|3]] | ||
* [[Hyper-IgM syndrome type 4|4]] | * [[Hyper-IgM syndrome type 4|4]] | ||
* [[Hyper-IgM syndrome type 5|5]]) | * [[Hyper-IgM syndrome type 5|5]]) | ||
| − | * [[ | + | * [[Wiskott–Aldrich syndrome]] |
* [[Hyperimmunoglobulin E syndrome|Hyper-IgE syndrome]] | * [[Hyperimmunoglobulin E syndrome|Hyper-IgE syndrome]] | ||
| − | |group3 | + | | group3 = Other |
| − | |list3 | + | | list3 = |
* [[Common variable immunodeficiency]] | * [[Common variable immunodeficiency]] | ||
* [[ICF syndrome]] | * [[ICF syndrome]] | ||
| − | }} | + | }} |
| − | + | | group2 = [[T cell deficiency]]<br/>([[T cell|T]]) | |
| − | + | | list2 = | |
* ''[[thymic hypoplasia]]:'' ''hypoparathyroid'' ([[DiGeorge syndrome|Di George's syndrome]]) | * ''[[thymic hypoplasia]]:'' ''hypoparathyroid'' ([[DiGeorge syndrome|Di George's syndrome]]) | ||
* ''euparathyroid'' ([[Nezelof syndrome]] | * ''euparathyroid'' ([[Nezelof syndrome]] | ||
| − | * [[ | + | * [[Ataxia–telangiectasia]]) |
| − | + | ''peripheral:'' [[Purine nucleoside phosphorylase deficiency]] | |
| − | * [[Hyper IgM syndrome]] ([[Hyper-IgM syndrome type 1|1]]) | + | * [[Hyper IgM syndrome]] ([[Hyper-IgM syndrome type 1|1]]) |
| − | + | | group3 = [[Severe combined immunodeficiency|Severe]] [[Combined immunodeficiencies|combined]]<br/>(B+T) | |
| − | + | | list3 = | |
* ''x-linked:'' [[X-linked severe combined immunodeficiency|X-SCID]]<br />''autosomal:'' [[Adenosine deaminase deficiency]] | * ''x-linked:'' [[X-linked severe combined immunodeficiency|X-SCID]]<br />''autosomal:'' [[Adenosine deaminase deficiency]] | ||
* [[Omenn syndrome]] | * [[Omenn syndrome]] | ||
| Line 53: | Line 51: | ||
* [[Bare lymphocyte syndrome]] | * [[Bare lymphocyte syndrome]] | ||
| − | + | }} | |
| − | + | | group2 = [[Immunodeficiency#acquired|Acquired]] | |
| − | + | | list2 = | |
| − | * [[AIDS]] | + | * [[HIV/AIDS]] |
| − | | | + | | group3 = [[Leukopenia]]:<br />[[Lymphocytopenia]] |
| − | | | + | | list3 = |
* [[Idiopathic CD4+ lymphocytopenia]] | * [[Idiopathic CD4+ lymphocytopenia]] | ||
| − | + | | group4 = [[Complement deficiency|Complement<br/>deficiency]] | |
| − | + | | list4 = | |
* ''[[C1-inhibitor]]'' ([[Angioedema]]/[[Hereditary angioedema]]) | * ''[[C1-inhibitor]]'' ([[Angioedema]]/[[Hereditary angioedema]]) | ||
* [[Complement 2 deficiency]]/[[Complement 4 deficiency]] | * [[Complement 2 deficiency]]/[[Complement 4 deficiency]] | ||
| Line 73: | Line 71: | ||
* [[Paroxysmal nocturnal hemoglobinuria]] | * [[Paroxysmal nocturnal hemoglobinuria]] | ||
* [[Complement receptor deficiency]] | * [[Complement receptor deficiency]] | ||
| − | |||
| − | |||
| − | |||
}}<noinclude> | }}<noinclude> | ||
| − | + | {{collapsible option}} | |
| − | |||
| − | |||
| − | |||
[[Category:Immunology templates]] | [[Category:Immunology templates]] | ||
</noinclude> | </noinclude> | ||
Latest revision as of 09:44, 9 December 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Lymphoid and complement immunodeficiency|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Lymphoid and complement immunodeficiency|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Lymphoid and complement immunodeficiency|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.